Welcome to the International Society for Vaccines
User account menu
Show — User account menu
Hide — User account menu
Log in
Sign Here
Login
Remember me
Remember password
Greetings: Create an account
Main navigation
Show — Main navigation
Hide — Main navigation
Home
ABOUT ISV
lebron 12 cork ebay - 308 - BQ6472 - Air Jordan 1 WMNS Mid Dark Teal Green
Air Jordan 9 IX Retro OG Space Jam , jordan retro 13 history of flight White Red Houston Rockets PE , IetpShops
SBD - nike blue air force 1 laces length chart size shoes - White x Nike blue Air Force 1 Low Brooklyn DX1419 - 300 Release Date , Off
air jordan 6 low insignia blue x jordan air sneaker socks , Grailify , Is a Nike SB x Air Jordan 4 "Pine Green" in the Pipeline?
Where To Buy , Nike Air Max 90 Leather LTHR Brigade Blue Armony Navy Sneakers Shoes 768887-401 , 600 - IetpShops , DO6485 , Nike Dunk Low GS Pink Velvet
air jordan 1 high stash white
417944 nike air max plus
air jordan 4 canyon purple release date
travis scott air jordan 1 low black phantom
Air Jordan 1 Mid Invert Split Black White DR0501 101 Release Date 4
ISV Constitution
ISV History
ISV Fellows
Officers & Board
Congress
Papers
Paper of the Year
Paper of the Month
Membership
Become An ISV Member
Existing Member Login
Main navigation
Show — Main navigation
Hide — Main navigation
Home
ABOUT ISV
ISV Constitution
ISV History
ISV Fellows
Officers & Board
Congress
Papers
Paper of the Year
Paper of the Month
Membership
Become An ISV Member
Existing Member Login
Skip to main content
ISV - The International Society for Vaccines
Breadcrumb
ISV Home
The Paper of month
The Paper of month
Date (field_date3)
And
December, 2013
Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
November, 2013
Immune clearance of highly pathogenic SIV infection
October, 2013
Microbiome, sex hormones, and immune responses in the reproductive tract: Challenges for vaccine development against sexually transmitted infections
September, 2013
Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial
August, 2013
Epitope engineering and molecular metrics of immunogenicAXity: A computational approach to VLP-based vaccine design
July, 2013
A brief history of the global effort to develop a preventive HIV vaccine
June, 2013
Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza
May, 2013
A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine
April, 2013
Boost Interval Matters: A Randomized Phase I Study to Identify the Minimum Interval to Observe the H5DNA Influenza Vaccine Priming Effect
March, 2013
Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
February, 2013
Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis
January, 2013
DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge